NCT03795519View on ClinicalTrials.gov

A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 17, 2019

Primary Completion Date

February 27, 2019

Study Completion Date

February 27, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

[14C]-olinciguat

oral capsule

Trial Locations (1)

53704

Covance Clinical Research Unit Inc., Madison

Sponsors
All Listed Sponsors
lead

Cyclerion Therapeutics

INDUSTRY